OLMA OLEMA PHARMACEUTICALS INC Expansion Plans 8-K Filing 2024 - Collaboration Agreement Olema Pharmaceuticals has entered into a collaboration agreement with Novartis for a clinical trial involving their drugs and completed a private placement of approximately $250 million by selling shares at $9.08 each.Get access to all SEC 8-K filings of the OLEMA PHARMACEUTICALS INC